ConductScience.org, home

Paper22992134

Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.

Gualandi F and 10 others. Hum Gene Ther, 2012. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy. Papers, record 22992134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22992134

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antisense-induced messenger depletion corrects a COL6A2 dominant mutation in Ullrich myopathy.
PubMed
Journal
Hum Gene Ther
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2025-05-29
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gualandi FFrancesca
2Manzati EElisa
3Sabatelli PPatrizia
4Passarelli CChiara
5Bovolenta MMatteo
6Pellegrini CCamilla
7Perrone DDaniela
8Squarzoni SStefano
9Pegoraro EElena
10Bonaldo PPaolo
11Ferlini AAlessandra

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Collagen Type VIMajor topic
Muscular DystrophiesMajor topic
MutationMajor topic
Oligoribonucleotides, AntisenseMajor topic
Cells, Cultured
Exons
Extracellular Matrix
Fibroblasts
Genes, Dominant
Humans
Nonsense Mediated mRNA Decay
Polymorphism, Single Nucleotide

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GUP07004TelethonItalyPubMed

Source PubMed

Download CSV of grants

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120302629Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies.BMC Med Genet2010https://conductscience.org/library/papers/20302629PubMed
219760747Exon skipping-mediated dystrophin reading frame restoration for small mutations.Hum Mutat2009https://conductscience.org/library/papers/19760747PubMed
322454058Overview on AON design.Methods Mol Biol2012https://conductscience.org/library/papers/22454058PubMed
421909428Targeting several CAG expansion diseases by a single antisense oligonucleotide.PLoS One2011https://conductscience.org/library/papers/21909428PubMed
521784508Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study.Lancet2011https://conductscience.org/library/papers/21784508PubMed
622172424Congenital muscular dystrophies: a brief review.Semin Pediatr Neurol2011https://conductscience.org/library/papers/22172424PubMed
720544328Delivery of siRNA therapeutics: barriers and carriers.AAPS J2010https://conductscience.org/library/papers/20544328PubMed
820211562166th ENMC International Workshop on Collagen type VI-related Myopathies, 22-24 May 2009, Naarden, The Netherlands.Neuromuscul Disord2010https://conductscience.org/library/papers/20211562PubMed
917886299Molecular consequences of dominant Bethlem myopathy collagen VI mutations.Ann Neurol2007https://conductscience.org/library/papers/17886299PubMed
1019906562RNA-targeting approaches for neuromuscular diseases.Trends Mol Med2009https://conductscience.org/library/papers/19906562PubMed
1121428760Systemic administration of PRO051 in Duchenne's muscular dystrophy.N Engl J Med2011https://conductscience.org/library/papers/21428760PubMed
1221943391ColVI myopathies: where do we stand, where do we go?Skelet Muscle2011https://conductscience.org/library/papers/21943391PubMed
1312218063Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy.J Biol Chem2002https://conductscience.org/library/papers/12218063PubMed
1421280092Large genomic deletions: a novel cause of Ullrich congenital muscular dystrophy.Ann Neurol2011https://conductscience.org/library/papers/21280092PubMed
1511691587Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts.Matrix Biol2001https://conductscience.org/library/papers/11691587PubMed
1619935778First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder.Mol Ther2010https://conductscience.org/library/papers/19935778PubMed
1719309692Identification and characterization of novel collagen VI non-canonical splicing mutations causing Ullrich congenital muscular dystrophy.Hum Mutat2009https://conductscience.org/library/papers/19309692PubMed
1817604456Modulating the expression of disease genes with RNA-based therapy.PLoS Genet2007https://conductscience.org/library/papers/17604456PubMed
1921037586Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration.Nat Med2010https://conductscience.org/library/papers/21037586PubMed

Download CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
40308063Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases.Mol Ther2025https://conductscience.org/library/papers/40308063PubMed
39595588Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts.Biomolecules2024https://conductscience.org/library/papers/39595588PubMed
39171142Allele-specific CRISPR-Cas9 editing inactivates a single nucleotide variant associated with collagen VI muscular dystrophy.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/39171142PubMed
38993932Strategies to improve the design of gapmer antisense oligonucleotide on allele-specific silencing.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38993932PubMed
38617974Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/38617974PubMed
36401021Current Strategies of Muscular Dystrophy Therapeutics: An Overview.Methods Mol Biol2023https://conductscience.org/library/papers/36401021PubMed
35457228CRISPR/Cas9-Mediated Allele-Specific Disruption of a Dominant COL6A1 Pathogenic Variant Improves Collagen VI Network in Patient Fibroblasts.Int J Mol Sci2022https://conductscience.org/library/papers/35457228PubMed
33441455Association of Initial Maximal Motor Ability With Long-term Functional Outcome in Patients With COL6-Related Dystrophies.Neurology2021https://conductscience.org/library/papers/33441455PubMed
32585628Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD.Mol Ther Nucleic Acids2020https://conductscience.org/library/papers/32585628PubMed
31447096Pathogenic Abnormal Splicing Due to Intronic Deletions that Induce Biophysical Space Constraint for Spliceosome Assembly.Am J Hum Genet2019https://conductscience.org/library/papers/31447096PubMed
31387942Basement membrane collagens and disease mechanisms.Essays Biochem2019https://conductscience.org/library/papers/31387942PubMed
31083481Antisense Oligonucleotide-Based Downregulation of the G56R Pathogenic Variant Causing NR2E3-Associated Autosomal Dominant Retinitis Pigmentosa.Genes (Basel)2019https://conductscience.org/library/papers/31083481PubMed
30895940A recurrent COL6A1 pseudoexon insertion causes muscular dystrophy and is effectively targeted by splice-correction therapies.JCI Insight2019https://conductscience.org/library/papers/30895940PubMed
28918041Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy.Mol Ther Nucleic Acids2017https://conductscience.org/library/papers/28918041PubMed
26945058Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy.J Cell Sci2016https://conductscience.org/library/papers/26945058PubMed
25204870Mosaicism for dominant collagen 6 mutations as a cause for intrafamilial phenotypic variability.Hum Mutat2015https://conductscience.org/library/papers/25204870PubMed
24959844Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts.Mol Ther Nucleic Acids2014https://conductscience.org/library/papers/24959844PubMed
24563484A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16.J Biol Chem2014https://conductscience.org/library/papers/24563484PubMed
24518369siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy.Mol Ther Nucleic Acids2014https://conductscience.org/library/papers/24518369PubMed
24038877Position of glycine substitutions in the triple helix of COL6A1, COL6A2, and COL6A3 is correlated with severity and mode of inheritance in collagen VI myopathies.Hum Mutat2013https://conductscience.org/library/papers/24038877PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
COL6A21292PubTator's text mininghttps://conductscience.org/library/genes/1292

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22992134

GET https://conductscience.org/api/papers/v1/22992134/authors